DAVITA INC. Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31)
DAVITA INC. (DVA) reported Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) of $13.47 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions · last filed 2018-02-23
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2017-12-31 was $7.43M, a 436.25% increase year-over-year.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2017-09-30 was $353.00K, a 89.48% decline year-over-year.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2017-06-30 was $4.60M, a 69.30% decline year-over-year.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2017-03-31 was $1.09M, a 87.41% decline year-over-year.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2017 was $13.47M, a 52.55% decline from fiscal 2016.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2016 was $28.40M, a 37.93% decline from fiscal 2015.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2015 was $45.75M, a 22.62% decline from fiscal 2014.
- DAVITA INC. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2014 was $59.12M, a 26.06% increase from fiscal 2013.
| Period end | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 3 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 6 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 9 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $7.78M derived: sum of 2 quarters · filed 2018-02-23 | $12.38M derived: sum of 3 quarters · filed 2018-02-23 | $13.47M 10-K · filed 2018-02-23 |
| 2017-09-30 | $353.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.96M derived: sum of 2 quarters · filed 2017-11-07 | $6.05M 10-Q · filed 2017-11-07 | $7.43M derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-06-30 | $4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $5.69M 10-Q · filed 2017-08-01 | $7.08M derived: sum of 3 quarters · filed 2018-02-23 | $10.43M derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-03-31 | $1.09M 10-Q · filed 2017-05-02 | $2.48M derived: sum of 2 quarters · filed 2018-02-23 | $5.83M derived: sum of 3 quarters · filed 2018-02-23 | $20.82M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $4.74M derived: sum of 2 quarters · filed 2018-02-23 | $19.73M derived: sum of 3 quarters · filed 2018-02-23 | $28.40M 10-K · filed 2018-02-23 |
| 2016-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $18.34M derived: sum of 2 quarters · filed 2017-11-07 | $27.01M 10-Q · filed 2017-11-07 | $41.69M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $14.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $23.66M 10-Q · filed 2017-08-01 | $38.34M derived: sum of 3 quarters · filed 2018-02-23 | $41.37M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $8.67M 10-Q · filed 2017-05-02 | $23.35M derived: sum of 2 quarters · filed 2018-02-23 | $26.38M derived: sum of 3 quarters · filed 2018-02-23 | $45.05M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $17.71M derived: sum of 2 quarters · filed 2018-02-23 | $36.38M derived: sum of 3 quarters · filed 2018-02-23 | $45.75M 10-K · filed 2018-02-23 |
| 2015-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $21.70M derived: sum of 2 quarters · filed 2016-11-02 | $31.07M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | $18.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $28.04M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $9.37M 10-Q · filed 2016-05-04 | |||
| 2014-12-31 | $59.12M 10-K · filed 2017-02-24 | |||
| 2014-03-31 | $22.98M 10-Q/A · filed 2015-05-08 | |||
| 2013-12-31 | $46.90M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $88.96M 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $38.20M 10-K · filed 2014-02-21 | |||
| 2010-12-31 | $26.71M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | $18.24M 8-K · filed 2012-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |